3138 results for «875»
3138 results
TAVI: coronary protection
17 Nov 2025 – From PCR London Valves 2025
This session addresses coronary protection strategies during TAVI procedures, especially in complex scenarios such as valve-in-valve interventions, small annulus, and high-risk anatomy. It covers advanced techniques like BASILICA and bioprosthetic valve fracture, providing expert guidance on overcoming challenges to prevent coronary artery obstruction and optimize procedural...
TAVI: technical tips and tricks
18 Nov 2025 – From PCR London Valves 2025
This session provides practical technical guidance for TAVI procedures emphasizing multimodality imaging for ultra-low contrast implantation, contrast-free techniques tailored for type 0 bicuspid aortic valves, and innovative bailout strategies for rapid pacing failure. It also covers advanced access management approaches in contrast-zero TAVI and current commissural...
TAVI: unusual complications - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session reviews unusual and severe complications encountered during TAVI procedures, such as aorto-right ventricular fistula, ventricular perforation, and sinus of Valsalva rupture. It highlights percutaneous treatment successes and endovascular interventions, offering critical insights into managing life-threatening procedural complications effectively.
Complications of mitral TEER
18 Nov 2025 – From PCR London Valves 2025
This session addresses complications associated with mitral transcatheter edge-to-edge repair (TEER), showcasing innovative bailout methods such as snare-assisted retrieval of undeployed devices, managing leaflet perforations with latest-generation devices, cases of valve-adjacent tears, mechanical support considerations when pumps fail, and the clinical impact of iatrogenic fossa ovalis...
Multiple valve interventions
17 Nov 2025 – From PCR London Valves 2025
This session delves into the complexities of multiple valve interventions, showcasing a fully transcatheter strategy for combined complex heart procedures. It presents stepwise approaches for managing multivalvular disease with severe pulmonary hypertension and sequential transcatheter strategies when single valve treatment is insufficient. Additional focus is given...
TAVI-in-TAVI - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session explores the evolving field of TAVI-in-TAVI interventions, presenting complex cases such as transfemoral TAVI-in-TAVI for degenerated transapical clip-fixed valves in transplanted hearts, management of very late TAVI migration in Bentall de Bono patients, TAVI for degenerated Evolut R valves, stepwise approaches to coronary protection...
Curious TAVI scenarios: solving complex anatomical and technical pitfalls
17 Nov 2025 – From PCR London Valves 2025
This session examines challenging and unusual scenarios encountered during transcatheter aortic valve implantation (TAVI). Topics include managing desaturation after transfemoral J-Valve implantation for pure NAVR, addressing procedural difficulties such as paddle release with Evolut TAVI, and utilizing snaring-assisted TAVI under cerebral embolic protection. It further explores...
Curious TAVI scenarios - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session examines unusual and challenging clinical scenarios following TAVI, including presentations of cyanosis, evolving valvular defects such as growing paravalvular holes, atypical imaging findings, paradoxical transvalvular gradients switching from aortic regurgitation to stenosis resolved by postdilatation, and bicoronary protection techniques in patients with low coronary...
Complications of transcatheter mitral valve replacement
17 Nov 2025 – From PCR London Valves 2025
This session addresses complications arising during transcatheter mitral valve replacement (TMVR), illustrated by challenging cases such as entangled snares, emergency interventions for prosthesis dislocation, vascular access difficulties, and repeat transapical mitral valve-in-valve replacements. It highlights the importance of anticipating and managing unexpected events to optimize patient...
TAVI - Haemodynamic performance and valve durability
18 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of haemodynamic performance and valve durability following transcatheter aortic valve implantation (TAVI). Attendees will gain a comprehensive understanding of the differences between invasive and echocardiographic gradients post-TAVI, evaluate the haemodynamic profiles of various transcatheter valve platforms, and appreciate their implications...
Highlights in valvular heart disease research - The year in EuroIntervention
17 Nov 2025 – From PCR London Valves 2025
This session highlights the most impactful research in valvular heart disease published in EuroIntervention in 2025. It reviews pivotal studies such as the ASCoP registry on complex PCI in severe aortic stenosis, the LANDMARK trial comparing Myval THV to other valves, and the D-PACE scoring system...
TAVI embolisation - Part 1
18 Nov 2025 – From PCR London Valves 2025
This session explores the critical issue of TAVI valve embolisation, presenting real-world cases that emphasize rapid problem-solving and interventional management strategies. Discussions include bailout techniques for embolised valves, managing multiple valve implantations in severe aortic stenosis, and expectations for TAVI in pure aortic regurgitation. The session...
TAVI device selection and implantation - A perspective for nurses and allied professionals
18 Nov 2025 – From PCR London Valves 2025
This session offers an in-depth perspective tailored for nurses and allied professionals on TAVI device selection and implantation. It covers critical assessment techniques for aortic stenosis severity, detailed patient selection criteria, and step-by-step procedural insights. Additionally, it provides a comprehensive overview of valve options including self-expanding...
Featured research: imaging innovation and device performance in TAVI
18 Nov 2025 – From PCR London Valves 2025
This session presents featured research on TAVI, highlighting long-term outcomes and innovations in transcatheter aortic valve therapy. It includes registry data on mild paravalvular leak impact, five-year evaluations of the Hydra THV, comparisons between deep learning and manual echocardiographic assessments, pacemaker implantation outcomes post-TAVI, and procedural...
TAVI embolisation - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session focuses on managing complications related to TAVI valve embolisation and migration. It includes detailed case discussions on balloon-expandable valve dislocation into the left ventricle, intra-annular migration managed by valve-in-valve techniques, and successful strategies for self-expanding valve migration. The session underscores the importance of readiness...
Paravalvular leak closure - Part 4
18 Nov 2025 – From PCR London Valves 2025
This session delves into the complexities of paravalvular leak closure with a focus on challenging scenarios including unusual TAVI complications in the mitral position, management of mega paravalvular leaks using jumbo devices, and strategies when closure itself poses an obstacle. It also covers acute peri-operative aortic...
FDA approves LimFlow system in patients with chronic limb-threatening ischemia and no suitable endovascular or surgical revascularization options
15 Sep 2023
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
